HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Efficacy and safety of combined paliperidone palmitate and olanzapine pamoate in resistant schizoaffective disorder.

AuthorsGuillaume Legrand, Méja Andrianarisoa, Joëlle Mauvieux, Isabelle Jalenques
JournalJournal of clinical psychopharmacology (J Clin Psychopharmacol) Vol. 34 Issue 5 Pg. 652-3 (Oct 2014) ISSN: 1533-712X [Electronic] United States
PMID25006816 (Publication Type: Case Reports, Letter)
Chemical References
  • Antipsychotic Agents
  • Delayed-Action Preparations
  • Drug Combinations
  • Benzodiazepines
  • Olanzapine
  • Paliperidone Palmitate
Topics
  • Antipsychotic Agents (administration & dosage, adverse effects, therapeutic use)
  • Benzodiazepines (administration & dosage, adverse effects, therapeutic use)
  • Delayed-Action Preparations (adverse effects, therapeutic use)
  • Drug Combinations
  • Drug Resistance
  • Humans
  • Male
  • Middle Aged
  • Olanzapine
  • Paliperidone Palmitate (administration & dosage, adverse effects, therapeutic use)
  • Psychotic Disorders (drug therapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: